跳至主要内容
临床试验/NCT06910683
NCT06910683尚未招募不适用

Technology dRiven Enhancement to Engage & Connect

Weill Medical College of Cornell University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2027年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Acceptability (Client Satisfaction Questionnaire; CSQ)

研究概览

简要总结

This study will investigate whether an intervention that includes remotely delivered therapy sessions and a digital mental health app, compared to only remotely delivered therapy reduces late-life depression

详细描述

Depression in mid- and late-life is characterized with reduced functions of the reward system. The investigators designed a psychotherapy that aims to improve reward functions through engagement in pleasurable activities and in turn reduce depression. Prior work has shown that this therapy is acceptable and reduces depression. This study examines whether a hybrid intervention that combines clinician remotely-delivered psychotherapy, and a novel app named TREE-Connect, reduces late life depression. This TREE-Connect app uses a machine learning algorithm to promote adherence to therapy (completion of therapeutic homework) in late-life depression and increase cost-effectiveness and reach of treatment to older adults. This randomized controlled trials will test whether the hybrid intervention (clinician-delivered psychotherapy + app), compared to a condition that includes solely clinician-delivered therapy is acceptable and reduces late-life depression.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 50-80
  • Capacity to provide consent for research assessment and treatment.
  • Significant depression, i.e., PHQ-9 ≥ 7 (mild-moderate severity of symptoms)
  • Mini Mental Status Exam (MMSE) equal or greater than a score of
  • Off antidepressants or on stable dose for 8 weeks and do not intend to change the dose in the next 10 weeks, without individual psychotherapy services during the study period.

排除标准

  • Intent or plan to commit suicide in the near future.
  • Inability to communicate in English.
  • History or presence of psychiatric diagnoses other than major depressive disorder without psychotic features, generalized anxiety disorder, specific phobia, or antisocial or borderline personality disorder.
  • Neurological disorders (dementias, amnestic and multidomain Mild Cognitive Impairment, Parkinson's disease, epilepsy, etc.).
  • Acute or severe medical illness in the past 3 months (metastatic cancer, multiple sclerosis, decompensated cardiac, liver or kidney failure, major surgery, stroke or myocardial infarction, cardiac, renal, or respiratory failure; severe chronic obstructive pulmonary disease, etc.) that may be the primary cause depressive symptoms, influence brain systems of interest, or impact ability to participate in the study.
  • For MRI only: Contraindications to MRI scanning including cardiac pacemaker, heart valve replacement, vascular stent, insulin pump, cochlear implant, any other metallic biomedical implant contraindicating to MRI, and claustrophobia.

研究组 & 干预措施

Clinician-delivered psychotherapy

Active Comparator

Participants will receive clinician-delivered psychotherapy without the TREE-Connect app

干预措施: Clinician-delivered psychotherapy (Behavioral)

TREE-Connect + Clinician-delivered psychotherapy

Experimental

Participants will receive a hybrid intervention that includes clinician-delivered psychotherapy and a TREE-Connect app

干预措施: TREE-Connect (Behavioral)

TREE-Connect + Clinician-delivered psychotherapy

Experimental

Participants will receive a hybrid intervention that includes clinician-delivered psychotherapy and a TREE-Connect app

干预措施: Clinician-delivered psychotherapy (Behavioral)

结局指标

主要结局

Acceptability (Client Satisfaction Questionnaire; CSQ)

时间窗: 9 Weeks

Acceptability will measured using the Client Satisfaction Questionnaire (CSQ) with a benchmar score of \>=3 (out of 4; average score); Range: 0 to 4, with higher scores indicating greater acceptability

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验